These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
917 related items for PubMed ID: 21979184
1. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis. Lindström L, Lapidus A, Ost A, Bergquist A. Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184 [Abstract] [Full Text] [Related]
2. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW. Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429 [Abstract] [Full Text] [Related]
3. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD. Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218 [Abstract] [Full Text] [Related]
4. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis. Lindberg J, Stenling R, Palmqvist R, Rutegård J. J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208 [Abstract] [Full Text] [Related]
6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Scand J Gastroenterol; 2009 May; 44(1):46-55. PubMed ID: 18609187 [Abstract] [Full Text] [Related]
7. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis. Svrcek M, Cosnes J, Beaugerie L, Parc R, Bennis M, Tiret E, Fléjou JF. Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493 [Abstract] [Full Text] [Related]
18. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Lindström L, Boberg KM, Wikman O, Friis-Liby I, Hultcrantz R, Prytz H, Sandberg-Gertzén H, Sangfelt P, Rydning A, Folvik G, Gangsøy-Kristiansen M, Danielsson A, Bergquist A. Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173 [Abstract] [Full Text] [Related]
19. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study. Terg R, Sambuelli A, Coronel E, Mazzuco J, Cartier M, Negreira S, Muñoz A, Gil A, Miguez C, Huernos S, Romero G, Goncalvez S, Levi D, Abecasis R. Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354 [Abstract] [Full Text] [Related]